CLINICAL_TRIALS
trial_result
· 2023-11-21
Clinical Trial Update: Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Summary
Phase 3 trial comparing T4032 to Lumigan in ocular hypertension or glaucoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratoires Thea | Conditions: Ocular Hypertension, Glaucoma | Phase 3 | Status: COMPLETED | Results posted: 2023-11-21